KOLLTAN PHARMACEUTICALS INC

Profile

Company Names

KOLLTAN PHARMACEUTICALS INC

Addresses

300 GEORGE STREET, SUITE 530, NEW HAVEN, CT 06511

Phone Numbers

203-773-3000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$133,500,000.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2014-03-13 
$60,000,000.00 
$60,000,000.00 
$0.00 
Equity 
4
2012-03-01 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
3
2009-12-29 
$2,500,000.00 
$2,500,000.00 
$0.00 
Equity 
2
2009-09-01 
$6,000,000.00 
$7,500,000.00 
$1,500,000.00 
Equity 
1
2008-07-24 
$40,000,000.00 
$40,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ARTHUR 
G. 
ALTSCHUL, JR. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
KOLLTAN PHARMACEUTICALS INC
ALEX 
 
BOLTE 
DIRECTOR
KOLLTAN PHARMACEUTICALS INC   |  OPHTHOTECH CORP.
AXEL 
 
BOLTE 
DIRECTOR
LUX BIOSCIENCES INC   |  KOLLTAN PHARMACEUTICALS INC   |  PTC THERAPEUTICS, INC.   |  OPHTHOTECH CORP.   |  ALLENA PHARMACEUTICALS, INC.   |  NABRIVA THERAPEUTICS PLC   |  INOZYME PHARMA, INC.
STANLEY 
 
CHOY 
EXECUTIVE OFFICER
KOLLTAN PHARMACEUTICALS INC   |  ALPHINA THERAPEUTICS, INC.
YARON 
 
HADARI 
EXECUTIVE OFFICER
KOLLTAN PHARMACEUTICALS INC
JANE 
PRITCHETT 
HENDERSON 
EXECUTIVE OFFICER
KOLLTAN PHARMACEUTICALS INC   |  OPHTHOTECH CORP.
K. 
PETER 
HIRTH 
DIRECTOR
KOLLTAN PHARMACEUTICALS INC   |  ALIGOS THERAPEUTICS, INC.
PETER 
 
HIRTH 
DIRECTOR
KOLLTAN PHARMACEUTICALS INC   |  ALIOS BIOPHARMA INC   |  AFFERENT PHARMACEUTICALS, INC.   |  ICONIC THERAPEUTICS INC   |  SUTROVAX, INC.   |  ALIGOS THERAPEUTICS, INC.   |  ESCIENT PHARMACEUTICALS INC   |  TREX HOLDINGS INC.
THERESA 
M. 
LAVALLEE 
EXECUTIVE OFFICER
KOLLTAN PHARMACEUTICALS INC
GERALD 
 
MCMAHON 
EXECUTIVE OFFICER, DIRECTOR
TRELLIS BIOSCIENCE INC   |  KOLLTAN PHARMACEUTICALS INC   |  HARPOON THERAPEUTICS, INC.
PAUL 
 
MEDEIROS 
DIRECTOR
KOLLTAN PHARMACEUTICALS INC   |  PRAXIS PRECISION MEDICINES, INC.
W. 
BRADFORD 
MIDDLEKAUFF 
EXECUTIVE OFFICER
KOLLTAN PHARMACEUTICALS INC   |  CASTLE CREEK BIOSCIENCES, INC.
THOMAS 
 
NEFF 
DIRECTOR
KOLLTAN PHARMACEUTICALS INC   |  GOVIEX URANIUM, INC.
THOMAS 
B. 
NEFF 
DIRECTOR
KOLLTAN PHARMACEUTICALS INC   |  FIBROGEN INC
JOSEPH 
 
SCHLESSINGER 
DIRECTOR, PROMOTER
KOLLTAN PHARMACEUTICALS INC   |  INOZYME PHARMA, INC.
MICHAEL 
 
SCHMERTZLER 
EXECUTIVE OFFICER, DIRECTOR
SEGWAY INC   |  KOLLTAN PHARMACEUTICALS INC   |  PTC THERAPEUTICS, INC.   |  SCHEDULICITY, INC.   |  AGNOVOS BIOSCIENCE, INC.
CAROLYN 
F. 
SIDOR 
EXECUTIVE OFFICER
ENTREMED INC   |  KOLLTAN PHARMACEUTICALS INC
E. 
JONATHAN 
SODERSTROM 
DIRECTOR
KOLLTAN PHARMACEUTICALS INC   |  HISTORX INC   |  ARTIZAN BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-03-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-13 
2012-03-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-01 
2010-09-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-01 
2010-01-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-29 
2009-09-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-01 
2009-08-12
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2008-07-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#